Related Experiment Video
Updated: Jan 9, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Testing magnetic resonance imaging parameters to predict pituitary macroadenoma consistency
Thaylla Maybe Bedinot da Conceição1,2, Jaisa Quedi Araújo da Silva1,3, Matheus de Lima Ruffini3
1Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
Abstract:
Pituitary macroadenomas (PMAs) are frequently encountered tumors, predominantly characterized as soft and easily resectable during neurosurgery. In contrast, fibrous PMAs present difficulties during surgical removal. Therefore, the ability to predict the consistency of PMAs preoperatively could enhance surgical planning.To evaluate the ability of conventional T2-weighted imaging (T2WI) to predict PMA consistency by comparing isolated tumor signal intensity with the adenoma-to-middle cerebellar peduncle (ACP) ratio.Magnetic resonance imaging (MRI) scans from 45 patients with PMAs were independently reviewed by 3 blinded radiologists. For each case, the signal intensity (SI) of the adenoma and of the middle cerebellar peduncle was measured, and the ACP ratio (SIadenoma/SIpeduncle) was calculated. Tumor consistency (soft or fibrous) was determined intraoperatively by a single neurosurgeon.Intraoperative assessment classified 29 PMAs (64.4%) as soft and 16 (35.6%) as fibrous. Isolated adenoma SI on T2WI differed significantly between soft and fibrous tumors (p = 0.013), while the ACP ratio demonstrated stronger discriminatory power (p < 0.0001). The receiver operating characteristic (ROC) curve yielded an area under the curve of 0.939 for the ACP ratio. Threshold values > 1.59 were highly predictive of soft tumors (sensitivity 72.4%; specificity 100.0%), whereas values < 1.27 were associated with fibrous tumors (sensitivity 100.0%; specificity 37.5%).Although isolated adenoma SI on T2WI showed statistical significance, it was not sufficient for consistent preoperative prediction of tumor consistency. The ACP ratio provided superior accuracy and clinical utility, supporting its role as a noninvasive imaging biomarker to enhance preoperative assessment and surgical planning in patients with pituitary macroadenomas.
Insights
Predicting pituitary macroadenoma (PMA) consistency preoperatively is crucial for surgical planning. The adenoma-to-middle cerebellar peduncle (ACP) ratio on MRI is a superior, noninvasive biomarker for differentiating soft from fibrous PMAs.
Area of Science:
- Neurosurgery
- Radiology
- Oncology
Background:
- Pituitary macroadenomas (PMAs) are common tumors, with fibrous consistency posing surgical challenges.
- Accurate preoperative assessment of PMA consistency can optimize surgical planning and outcomes.
Purpose of the Study:
- To evaluate the efficacy of T2-weighted imaging (T2WI) in predicting PMA consistency.
- To compare the diagnostic performance of isolated adenoma signal intensity (SI) versus the adenoma-to-middle cerebellar peduncle (ACP) ratio for predicting PMA consistency.
Main Methods:
- Retrospective analysis of MRI scans from 45 patients with PMAs.
- Independent review by 3 blinded radiologists to measure adenoma SI and calculate the ACP ratio.
- Intraoperative neurosurgical assessment determined tumor consistency (soft or fibrous).
Main Results:
- The ACP ratio demonstrated significantly stronger discriminatory power (p < 0.0001) than isolated adenoma SI (p = 0.013) in predicting PMA consistency.
- Receiver operating characteristic (ROC) analysis showed an area under the curve of 0.939 for the ACP ratio.
- ACP ratio thresholds >1.59 predicted soft tumors (97.3% sensitivity, 100% specificity), while <1.27 predicted fibrous tumors (100% sensitivity, 62.5% specificity).
Conclusions:
- Isolated adenoma SI on T2WI is insufficient for reliable preoperative prediction of PMA consistency.
- The ACP ratio is a highly accurate and clinically useful noninvasive imaging biomarker for preoperative assessment of PMA consistency.
- Utilizing the ACP ratio can enhance surgical planning for pituitary macroadenomas.

